82 related articles for article (PubMed ID: 23796710)
1. Isolation and characterization of human breast cancer cells with SOX2 promoter activity.
Liang S; Furuhashi M; Nakane R; Nakazawa S; Goudarzi H; Hamada J; Iizasa H
Biochem Biophys Res Commun; 2013 Jul; 437(2):205-11. PubMed ID: 23796710
[TBL] [Abstract][Full Text] [Related]
2. β-Catenin, a Sox2 binding partner, regulates the DNA binding and transcriptional activity of Sox2 in breast cancer cells.
Ye X; Wu F; Wu C; Wang P; Jung K; Gopal K; Ma Y; Li L; Lai R
Cell Signal; 2014 Mar; 26(3):492-501. PubMed ID: 24291232
[TBL] [Abstract][Full Text] [Related]
3. Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity.
Wu F; Zhang J; Wang P; Ye X; Jung K; Bone KM; Pearson JD; Ingham RJ; McMullen TP; Ma Y; Lai R
Cell Signal; 2012 Nov; 24(11):1989-98. PubMed ID: 22800865
[TBL] [Abstract][Full Text] [Related]
4. Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarrays.
Jung K; Wang P; Gupta N; Gopal K; Wu F; Ye X; Alshareef A; Bigras G; McMullen TP; Abdulkarim BS; Lai R
Breast Cancer Res; 2014 Nov; 16(6):470. PubMed ID: 25380620
[TBL] [Abstract][Full Text] [Related]
5. Characteristic genes in luminal subtype breast tumors with CD44+CD24-/low gene expression signature.
Tsunoda Y; Sakamoto M; Sawada T; Sasaki A; Yamamoto G; Tachikawa T
Oncology; 2011; 81(5-6):336-44. PubMed ID: 22237177
[TBL] [Abstract][Full Text] [Related]
6. YB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cells.
Jung K; Wu F; Wang P; Ye X; Abdulkarim BS; Lai R
BMC Cancer; 2014 May; 14():328. PubMed ID: 24885403
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
[TBL] [Abstract][Full Text] [Related]
8. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
9. Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression.
Zhang F; Song C; Ma Y; Tang L; Xu Y; Wang H
Int J Mol Med; 2011 Sep; 28(3):365-71. PubMed ID: 21573501
[TBL] [Abstract][Full Text] [Related]
10. Positive regulation of additional sex comb-like 1 gene expression by the pluripotency factor SOX2.
Kang M; Lee SW; Kim EJ; Um SJ
Biochem Biophys Res Commun; 2012 May; 421(3):621-6. PubMed ID: 22542624
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress induces the acquisition of cancer stem-like phenotype in breast cancer detectable by using a Sox2 regulatory region-2 (SRR2) reporter.
Gopal K; Gupta N; Zhang H; Alshareef A; Alqahtani H; Bigras G; Lewis J; Douglas D; Kneteman N; Lavasanifar A; Lai R
Oncotarget; 2016 Jan; 7(3):3111-27. PubMed ID: 26683522
[TBL] [Abstract][Full Text] [Related]
12. DDX17 (P72), a Sox2 binding partner, promotes stem-like features conferred by Sox2 in a small cell population in estrogen receptor-positive breast cancer.
Alqahtani H; Gopal K; Gupta N; Jung K; Alshareef A; Ye X; Wu F; Li L; Lai R
Cell Signal; 2016 Feb; 28(2):42-50. PubMed ID: 26569340
[TBL] [Abstract][Full Text] [Related]
13. NONO Is a Negative Regulator of
Liang S; Takahashi H; Hirose T; Kuramitsu Y; Hatakeyama S; Yoshiyama H; Wang R; Hamada JI; Iizasa H
Cancer Genomics Proteomics; 2020; 17(4):359-367. PubMed ID: 32576581
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells.
Dong Y; Asch HL; Ying A; Asch BB
Exp Cell Res; 2002 Jun; 276(2):328-36. PubMed ID: 12027462
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
[TBL] [Abstract][Full Text] [Related]
16. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
17. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult.
Ellis P; Fagan BM; Magness ST; Hutton S; Taranova O; Hayashi S; McMahon A; Rao M; Pevny L
Dev Neurosci; 2004; 26(2-4):148-65. PubMed ID: 15711057
[TBL] [Abstract][Full Text] [Related]
18. CREB-1 and AP-1 transcription factors JunD and Fra-2 regulate bone sialoprotein gene expression in human breast cancer cells.
Detry C; Lamour V; Castronovo V; Bellahcène A
Bone; 2008 Feb; 42(2):422-31. PubMed ID: 18088579
[TBL] [Abstract][Full Text] [Related]
19. Identification of DPPA4 and other genes as putative Sox2:Oct-3/4 target genes using a combination of in silico analysis and transcription-based assays.
Chakravarthy H; Boer B; Desler M; Mallanna SK; McKeithan TW; Rizzino A
J Cell Physiol; 2008 Sep; 216(3):651-62. PubMed ID: 18366076
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomics on SOX2 orthologs.
Katoh Y; Katoh M
Oncol Rep; 2005 Sep; 14(3):797-800. PubMed ID: 16077994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
